or Try an Advanced Search...

    Technical Analysis for CTX - Crescita Therapeutics Inc.

    Grade Last Price % Change Price Change
    B 0.610 1.67% 0.010
    CTX closed up 1.67 percent on Friday, July 26, 2024, on 2 percent of normal volume.
    Earnings due: Aug 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CTX trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Calm After Storm Range Contraction 1.67%
    Narrow Range Bar Range Contraction 1.67%
    Wide Bands Range Expansion 1.67%
    Upper Bollinger Band Walk Strength 1.67%
    Wide Bands Range Expansion 1.67%
    Gapped Down Weakness 1.67%
    Older End-of-Day Signals for CTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    Up 1% about 9 hours ago
    5x Volume Pace 2 days ago
    3x Volume Pace 3 days ago
    2x Volume Pace 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CTX Chart by TradingView
    Basic chart:

    Profile

    Crescita Therapeutics Inc. Description

    Crescita Therapeutics Inc. is a drug development company. The Company owns products for treating medical conditions in dermatology and pain. It owns various drug delivery platforms, which include Durapeel and Foam technology to support the development of patented formulations that can deliver actives into or through the skin. It operates two business units: the Topical Products and Technology (TPT) Group and the Immunology Group. The TPT Group product, Pliaglis and other products are focused on dermatology and pain. Its product Flexicaine is in Phase II clinical stage and has therapeutic area in Tick-borne disease. Its product Ibuprofen Foam is in pre-clinical stage and has therapeutic area in Acute Pain. Its product Terbinafine is in pre-clinical stage and has therapeutic area in Onychomycosis. Its product Mical 1 is in pre-clinical stage and has therapeutic area in Psoriasis. Its product Mical 2 is in pre-clinical stage and has therapeutic area in Dermatological skin treatment.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Delivery Clinic Drug Pain Disease RTT Skin Drugs Medical Specialties Organ Systems Immunology Drug Development Dermatology Drug Delivery Psoriasis Acute Pain Onychomycosis Topical Products

    Is CTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 22 Crescita Therapeutics Secures US$10 Million, 4-Year Manufacturing Contract
    Jul 22 Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
    Jul 19 Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
    Jul 17 Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
    Jun 26 Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
    Jun 20 Crescita to Acquire Strategic Assets of Occy Laboratory
    Jun 6 Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
    May 30 Here's Why Shareholders Should Examine Crescita Therapeutics Inc.'s (TSE:CTX) CEO Compensation Package More Closely
    May 8 Crescita Reports First Quarter 2024 Results
    Mar 13 Crescita Reports Q4 and Fiscal 2023 Results
    See more CTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.73
    52 Week Low 0.36
    Average Volume 26,125
    200-Day Moving Average 0.521
    50-Day Moving Average 0.471
    20-Day Moving Average 0.526
    10-Day Moving Average 0.566
    Average True Range 0.025
    RSI (14) 70.50
    ADX 23.58
    +DI 54.127
    -DI 27.380
    Chandelier Exit (Long, 3 ATRs) 0.615
    Chandelier Exit (Short, 3 ATRs) 0.485
    Upper Bollinger Bands 0.653
    Lower Bollinger Band 0.399
    Percent B (%b) 0.83
    BandWidth 48.299
    MACD Line 0.043
    MACD Signal Line 0.033
    MACD Histogram 0.0099
    Fundamentals Value
    Market Cap 12.6 Million
    Num Shares 20.6 Million
    EPS 0.01
    Price-to-Earnings (P/E) Ratio 87.14
    Price-to-Sales 1.08
    Price-to-Book 0.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.610
    Resistance 3 (R3) 0.610 0.610 0.610
    Resistance 2 (R2) 0.610 0.610 0.610 0.610
    Resistance 1 (R1) 0.610 0.610 0.610 0.610 0.610
    Pivot Point 0.610 0.610 0.610 0.610 0.610
    Support 1 (S1) 0.610 0.610 0.610 0.610 0.610
    Support 2 (S2) 0.610 0.610 0.610 0.610
    Support 3 (S3) 0.610 0.610 0.610
    Support 4 (S4) 0.610